• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The international system for staging lung cancer.

作者信息

Mountain C F

机构信息

Division of Cardiothoracic Surgery, The University of California at San Diego, San Diego, California, USA.

出版信息

Semin Surg Oncol. 2000 Mar;18(2):106-15. doi: 10.1002/(sici)1098-2388(200003)18:2<106::aid-ssu4>3.0.co;2-p.

DOI:10.1002/(sici)1098-2388(200003)18:2<106::aid-ssu4>3.0.co;2-p
PMID:10657912
Abstract

The International System for Staging Lung Cancer is a consistent, reproducible classification for the anatomic extent of disease in patients with lung cancer. A revision of the system in use since 1986 included modifications of the rules for stage grouping the TNM (T-primary tumor, N-regional lymph nodes, and M-distant metastasis) anatomic subsets. More specific stage categories and consistency for reporting the end results for Stage I, Stage II, and Stage IIIA disease are provided. Survival data support the revised categories and confirm the significant relationship between the extent of the disease and prognosis for patients with this disease.

摘要

相似文献

1
The international system for staging lung cancer.
Semin Surg Oncol. 2000 Mar;18(2):106-15. doi: 10.1002/(sici)1098-2388(200003)18:2<106::aid-ssu4>3.0.co;2-p.
2
Revisions in the International System for Staging Lung Cancer.《国际肺癌分期系统的修订》
Chest. 1997 Jun;111(6):1710-7. doi: 10.1378/chest.111.6.1710.
3
The new International Staging System for Lung Cancer.肺癌新国际分期系统。
Surg Clin North Am. 1987 Oct;67(5):925-35. doi: 10.1016/s0039-6109(16)44330-6.
4
The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.国际肺癌研究协会肺癌分期项目：关于即将出版的（第七版）肺癌肿瘤、淋巴结、转移分类中对小细胞肺癌临床分期的建议。
J Thorac Oncol. 2007 Dec;2(12):1067-77. doi: 10.1097/JTO.0b013e31815bdc0d.
5
Staging of lung cancer.肺癌的分期
Yale J Biol Med. 1981 May-Jun;54(3):161-72.
6
Implications of staging in lung cancer.肺癌分期的意义。
Chest. 1997 Oct;112(4 Suppl):242S-248S. doi: 10.1378/chest.112.4_supplement.242s.
7
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.国际口咽癌协作网（ICON-S）制定和验证 HPV 相关口咽癌分期系统：一项多中心队列研究。
Lancet Oncol. 2016 Apr;17(4):440-451. doi: 10.1016/S1470-2045(15)00560-4. Epub 2016 Feb 27.
8
The revised TNM staging system for lung cancer.修订后的肺癌TNM分期系统。
Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):4-9.
9
[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].基于分期分类的非小细胞肺癌完全手术切除后的预后
Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. doi: 10.1055/s-2006-956268.
10
Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry.利用加利福尼亚癌症登记处的数据对国际肺癌研究协会提出的晚期细支气管肺泡癌非小细胞肺癌分期系统修订版进行验证。
J Thorac Oncol. 2007 Dec;2(12):1078-85. doi: 10.1097/JTO.0b013e31815ba260.

引用本文的文献

1
Impact of Waiting Times on Mortality in Advanced Stage Non-Small Cell Lung Cancer: A 10-Year Retrospective Cohort Study in Thailand.晚期非小细胞肺癌患者等待时间对死亡率的影响：泰国一项长达 10 年的回顾性队列研究。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3419-3428. doi: 10.31557/APJCP.2023.24.10.3419.
2
Lidocaine induces epithelial‑mesenchymal transition and aggravates cancer behaviors in non‑small cell lung cancer A549 cells.利多卡因诱导非小细胞肺癌A549细胞发生上皮-间质转化并加重癌症行为。
Oncol Lett. 2023 Jun 27;26(2):346. doi: 10.3892/ol.2023.13932. eCollection 2023 Aug.
3
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer.
分析肿瘤内免疫异质性突出了免疫调节和共抑制淋巴细胞作为 I 期非小细胞肺癌复发的标志。
Mod Pathol. 2023 Jan;36(1):100028. doi: 10.1016/j.modpat.2022.100028.
4
Validation of Pretreatment Prognostic Factors and Prognostic Staging Systems for Small Cell Lung Cancer in a Real-World Data Set.真实世界数据集中小细胞肺癌预处理预后因素及预后分期系统的验证
Cancers (Basel). 2022 May 25;14(11):2625. doi: 10.3390/cancers14112625.
5
Surgery in Small-Cell Lung Cancer.小细胞肺癌的外科治疗
Cancers (Basel). 2021 Jan 21;13(3):390. doi: 10.3390/cancers13030390.
6
Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.国家肺癌筛查试验中通过筛查发现的 I 期肺癌患者的生存情况。
Chest. 2021 Feb;159(2):862-869. doi: 10.1016/j.chest.2020.08.2048. Epub 2020 Aug 19.
7
Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer.I-III期小细胞肺癌患者手术及非手术治疗的生存结果
J Cancer. 2018 Apr 6;9(8):1421-1429. doi: 10.7150/jca.23583. eCollection 2018.
8
Clinicopathological and prognostic significance of circulating tumor cells in patients with lung cancer: a meta-analysis.肺癌患者循环肿瘤细胞的临床病理特征及预后意义：一项荟萃分析
Oncotarget. 2017 Jul 10;8(37):62524-62536. doi: 10.18632/oncotarget.19122. eCollection 2017 Sep 22.
9
Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.小白菊内酯通过B-Raf/MAPK/Erk信号通路抑制非小细胞肺癌GLC-82细胞的生长。
Oncotarget. 2017 Apr 4;8(14):23436-23447. doi: 10.18632/oncotarget.15584.
10
Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer.节拍化疗联合贝伐单抗治疗晚期非鳞状非小细胞肺癌的II期试验性研究
Lung Cancer. 2017 Apr;106:125-130. doi: 10.1016/j.lungcan.2017.02.004. Epub 2017 Feb 9.